Design, synthesis, antiviral and cytostatic evaluation of novel isoxazolidine nucleotide analogues with a 1,2,3-triazole linker

Eur J Med Chem. 2012 Jan;47(1):501-9. doi: 10.1016/j.ejmech.2011.11.021. Epub 2011 Nov 20.

Abstract

Azidation (TMSN(3), SnCl(4)) of a 9:1 mixture of trans- and cis-5-acetoxy-2-methylisoxazolidin-3-yl-3-phosphonates at the anomeric carbon atom led to the formation of the equimolar mixture of cis- and trans-5-azido-2-methylisoxazolidin-3-yl-3-phosphonates, which were efficiently separated. The 1,3-dipolar cycloaddition of pure trans- and cis-5-azidoisoxazolidin-3-yl-3-phosphonates with selected alkynes gave the respective nucleoside mimetics containing a 1,2,3-triazole linker. The (1,2,3-triazolyl)isoxazolidine phosphonates obtained herein were evaluated in vitro for activity against a variety of DNA and RNA viruses. None of the compounds were endowed with antiviral activity at subtoxic concentrations. Compounds 15f-j and 16f-j were cytostatic in the higher micromolar range.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / chemical synthesis
  • Antiviral Agents / chemistry
  • Antiviral Agents / pharmacology
  • Antiviral Agents / toxicity
  • Cell Line
  • Cytostatic Agents / chemical synthesis
  • Cytostatic Agents / chemistry
  • Cytostatic Agents / pharmacology
  • Cytostatic Agents / toxicity
  • Drug Design*
  • Humans
  • Inhibitory Concentration 50
  • Mice
  • Nucleotides / chemical synthesis
  • Nucleotides / chemistry
  • Nucleotides / pharmacology*
  • Nucleotides / toxicity*
  • Triazoles / chemistry*
  • Viruses / drug effects*

Substances

  • Antiviral Agents
  • Cytostatic Agents
  • Nucleotides
  • Triazoles